What’s New
We share news about new product features, our thoughts on recent developments at MedaSystems or in the industry at large. Scroll down for a chronological view, or jump to posts using the categories to the left.
From Expanded Access to FDA Approval: What the Revolution Medicines Story Signals for Biopharma
Expanded Access programs often sit at the intersection of urgent patient need, regulatory complexity and operational readiness. The recent experience of Revolution Medicines offers a compelling example of how quickly that intersection can come into focus.
Lessons From the Field: What Expanded Access Teaches Us About Patients, Data, and Drug Development
Expanded access programs—sometimes called compassionate use—often enter a company’s world unexpectedly. A single request from a physician or patient can quickly become a defining moment that tests a company’s preparedness, values, and systems.